tizanidine: Clinical Trials

5 trials of tizanidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Withdrawn 1
Phase 11Completed 1

Follow tizanidine: new trials by email Literature Review of tizanidine trials Research Report on tizanidine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study
Tizanidine, Standard-of-Care Therapy - Post Operative, Post Operative Analgesia
Phase 2RecruitingHartford Hospital1862026-08-212026-09-21
Gabapentin and Tizanidine for Insomnia in Chronic Pain
Gabapentin, Placebo, Tizanidine - Insomnia Due to Medical Condition, Chronic Pain
Phase 2CompletedUniversity of California, San Diego92020-07-292025-01-03
Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain
SPARC1401-low dose, SPARC1401-mid dose, SPARC1401-high dose - Acute Muscle Pain
Phase 2WithdrawnSun Pharma Advanced Research Company Limited2016-11-012019-05-03
A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial
Tizanidine, Placebo, Moxifloxacin - Spasticity
Phase 2CompletedAcorda Therapeutics1362013-04-012021-03-23
Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Tizanidine (sublingual or oral) - Muscle Spasticity
Phase 1 / Phase 2CompletedTeva GTC202006-12-012009-01-21

Conditions studied

Muscle Spasticity (2)  ·  Chronic Pain (1)  ·  Multiple Sclerosis (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Sponsors

Acorda Therapeutics (1)  ·  Hartford Hospital (1)  ·  Sun Pharma Advanced Research Company Limited (1)  ·  Teva GTC (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Israel (1)

Top investigators

Arnon Karni, MD (1)  ·  Elena Tunitsky, MD (1)  ·  Mathews Adera, MD (1)  ·  Nathaniel Schuster, MD (1)  ·  Sindhura Vallabhaneni, MD (1)

Results publications

PMID 11130605, PMID 12269398, PMID 16038812, PMID 20223444, PMID 26555871, PMID 27521884, PMID 38529017, PMID 41687037, PMID 41854462, PMID 8080219, PMID 8646957

NIH funding

UL1TR000100 (1)